| 标题 |
 Revefenacin, a once-daily, lung-selective, long-acting muscarinic antagonist for nebulized therapy: Safety and tolerability results of a 52-week phase 3 trial in moderate to very severe chronic obstructive pulmonary disease |
| 网址 | |
| DOI | |
| 其它 |
期刊：Respiratory Medicine 作者：James F. Donohue; Edward Kerwin; Sanjay Sethi; Brett Haumann; Srikanth Pendyala; et al 出版日期：2019-07-01 |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
invisight
璐璐
DW
林狗
极限001
嘻嘻哈哈
aaaa
pluto
学术文献互助
123
v0id
现实的波波
maxiaole
xing_xing
123
重要柠檬
aajhajkahna
木子
DOC_XIONG
kk
皖公网安备34019202002308
